The highest numbers of breast and cervical cancer deaths are found mostly in southeastern states, according to new data from the "2024 State Scorecard on Women’s Health and Reproductive Care" released July 18 by The Commonwealth Fund.
The Latest
The drug cyclophosphamide prevented bone marrow transplant complications for patients with "mismatched" donors, according to a study published July 17 in the Journal of Clinical Oncology.
Existing screening protocols in place are failing to identify patients who might be carriers of a genetic mutation that is linked to certain cancers, according to Mayo Clinic researchers.
An EHR reminder, or "nudge," can reduce unnecessary breast cancer surgeries, according to a study published July 17 in JAMA Surgery.
Eugene Kim, MD, has been named surgeon-in-chief and associate director of surgery at Torrance, Calif.-based Cedars-Sinai Guerin Children's.
A University of California Irvine study reported 90% patient satisfaction in cancer patients who were offered a multilanguage electronic tool to report their symptoms.
A clinical trial conducted by researchers at Rochester, Minn.-based Mayo Clinic and Minneapolis-based University of Minnesota found drug combinations eliminated or shrunk tumors in 70% of clinical trial participants with stage 3 melanoma.
The FDA has given fast-track designation to Diakonos Oncology for its pancreatic cancer vaccine.
Tampa (Fla.) General Hospital has received a "substantial" gift to develop a center of colorectal cancer excellence.
The median compensation for hematologists and medical oncologists increased 7.1% from 2023 to 2024, going from $498,062 to $533,402, according to the American Medical Group Association.